Research Overview of Clomiphene Citrate
Clomiford 50 mg is a pharmaceutical-grade clomiphene citrate formulation manufactured by Johnlee Pharmaceuticals for specialized laboratory research. Clomiphene citrate is a non-steroidal selective estrogen receptor modulator (SERM) with established clinical research applications. This compound demonstrates dual mechanisms of action, functioning as an estrogen receptor antagonist in hypothalamic tissue while exhibiting agonistic properties in other target tissues. Researchers investigating hormonal modulation pathways and reproductive endocrinology will find this Stroid UK Shop provides consistent quality for demanding laboratory protocols.
Laboratory Applications and Research Contexts
Clomiphene citrate serves as a valuable reference compound in studies examining estrogen receptor signaling cascades and gonadotropin release mechanisms. The compound’s well-documented pharmacological profile makes it suitable for comparative analyses in reproductive biology research and endocrine pathway investigations. Laboratory studies have utilized clomiphene citrate to examine hypothalamic-pituitary-gonadal axis function, estrogen receptor binding affinities, and downstream cellular responses. Research applications extend to metabolic studies, as clomiphene citrate influences various hormonal cascades beyond reproductive pathways. Scientists studying post cycle therapy compounds frequently incorporate this SERM into their experimental protocols due to its established mechanism of action and extensive published literature.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Clomiphene Citrate |
| Concentration | 50 mg per tablet |
| Manufacturer | Johnlee Pharmaceuticals |
| CAS Number | 50-41-9 |
| Molecular Formula | C₃₂H₃₆ClNO₈ |
| Molecular Weight | 598.08 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Form | Oral tablets |
This pharmaceutical-grade formulation ensures consistent potency for research applications requiring precise compound concentrations. Researchers examining comparative efficacy with other selective modulators often reference studies using similar formulations to establish baseline parameters. The established pharmacokinetic profile of clomiphene citrate facilitates research design and protocol development. Scientists investigating selective androgen receptor modulators may utilize clomiphene citrate as a comparative SERM in cross-pathway studies. Additionally, researchers studying peptide hormones often incorporate SERM compounds to examine endocrine interactions and regulatory mechanisms.
Research Compliance and Laboratory Use
Clomiford 50 mg is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. All purchases must comply with applicable research regulations and institutional guidelines governing controlled substances and research chemicals. Researchers must maintain appropriate documentation and storage protocols as required by their institutional review boards and regulatory authorities. This product should only be handled by qualified laboratory personnel with appropriate training in research chemical safety procedures.




